Table 3.
Complete list of analyzed cytokines in alphabetical order.
| Human Cytokine Array G5 | ||||
|---|---|---|---|---|
| Angiogenin | BDNF | BLC (CXCL13) |
CK b 8-1 (CCL23) |
EGF |
| ENA-78 (CXCL5) |
Eotaxin (CCL11) |
Eotaxin-2 (MPIF-2/CCL24) |
Eotaxin-3 (CCL26) |
FGF-4 |
| FGF-6 | FGF-7 (KGF) |
FGF-9 | Flt-3 Ligand | Fractalkine (CX3CL1) |
| GCP-2 (CXCL6) |
GCSF | GDNF | GM-CSF | GRO-a (CXCL1) |
| GRO | HGF | I-309 (TCA-3/CCL1) |
IFN-g | IGF-I |
| IGFBP-1 | IGFBP-2 | IGFBP-3 | IGFBP-4 | IL-1a (IL-1 F1) |
| IL-1 b (IL-1 F2) |
IL-2 | IL-3 | IL-4 | IL-5 |
| IL-6 | IL-7 | IL-8 (CXCL8) |
IL-10 | IL-12 p40/p70 |
| IL-13 | IL-15 | IL-16 | IP-10 (CXCL10) |
Leptin |
| LIF | LIGHT (TNFSF14) |
MCP-1 (CCL2) |
MCP-2 (CCL8) |
MCP-3 (MARC/CCL7) |
| MCP-4 (CCL13) |
MCSF | MDC (CCL22) |
MIF | MIG (CXCL9) |
| MIP-1b (CCL4) |
MIP-1d (CCL15) |
MIP-3 a (CCL20) |
NAP-2 (PPBP/CXCL7) |
NT-3 |
| NT-4 | Oncostatin M | Osteopontin (SPP1) |
Osteoprotegerin (TNFRSF11B) |
PARC (CCL18) |
| PDGF-BB | PlGF | RANTES (CCL5) |
SCF | SDF-1 alpha (CXCL12 alpha) |
| TARC (CCL17) |
TGF-β 1 | TGF-β 2 | TGF-β 3 | Thrombopoietin (TPO) |
| TIMP-1 | TIMP-2 | TNF-α | TNF-β (TNFSF1B) |
VEGF |
BDNF—Brain-derived neurotrophic factor; BLC—B lymphocyte chemoattractant; CK b 8-1 (CCL23)—C-C motif chemokine 23; EGF—Pro-epidermal growth factor; ENA-78—Epithelial-derived neutrophil-activating protein 78; FGF-4—Fibroblast growth factor 4; FGF-6—Fibroblast growth factor 6; FGF-7—Fibroblast growth factor 7; FGF-9—Fibroblast growth factor 9; Flt-3 Ligand—Fms-related tyrosine kinase 3 ligand; GCP-2—Granulocyte chemotactic protein 2; GCSF—Granulocyte colony-stimulating factor; GDNF—Glial cell line-derived neurotrophic factor; GM-CSF—Granulocyte–macrophage colony-stimulating factor; GRO-a—Growth-regulated alpha protein; GRO—Reacts with CXCL1, CXCL2, and CXCL3 (GRO alpha, beta, and gamma, respectively); HGF—Hepatocyte growth factor; I-309 (CCL1)—C-C motif chemokine 1; IFN-g—Interferon gamma; IGF-I—Insulin-like growth factor I; IGFBP-1—Insulin-like growth factor-binding protein 1; IGFBP-2—Insulin-like growth factor-binding protein 2; IGFBP-3—Insulin-like growth factor-binding protein 3; IGFBP-4—Insulin-like growth factor-binding protein 4; IL-1a—Interleukin-1 alpha; IL-1 b—Interleukin-1 beta; IL-2—Interleukin-2; IL-3—Interleukin-3; IL-4—Interleukin-4; IL-5—Interleukin-5; IL-6—Interleukin-6; IL-7—Interleukin-7; IL-8—Interleukin-8; IL-10—Interleukin-10; IL-12—Interleukin-12; IL-13—Interleukin-13; IL-15—Interleukin-15; IL-16—Interleukin-16; IP-10—Interferon gamma-induced protein; LIF—Leukemia inhibitory factor; LIGHT (TNFSF14)—Tumor necrosis factor ligand superfamily member 14; MCP-1—Monocyte chemoattractant protein 1; MCP-2—Monocyte chemoattractant protein 2; MCP-3—Monocyte chemoattractant protein 3; MCP-4—Monocyte chemoattractant protein 4; MCSF—Macrophage colony-stimulating factor 1; MDC—Macrophage-derived chemokine; MIF—Macrophage migration inhibitory factor; MIG—Monokine induced by interferon-gamma; MIP-1b—Macrophage inflammatory protein 1-beta; MIP-1d—Macrophage inflammatory protein 1-delta; MIP-3 a—Macrophage inflammatory protein 3 alpha; NAP-2—Neutrophil-activating peptide 2; NT-3—Neurotrophin-3; NT-4—Neurotrophin-4; PARC—Pulmonary and activation-regulated chemokine; PDGF-BB—Platelet-derived growth factor subunit B; PlGF—Placenta growth factor; RANTES (CCL5)—C-C motif chemokine 5; SCF—Stem cell factor; SDF-1—Stromal cell-derived factor 1; TARC(CCL17); TGF-β 1—Transforming growth factor beta-1; TGF-β 2—Transforming growth factor beta-2; TGF-β 3—Transforming growth factor beta-3; TIMP-1—Metalloproteinase inhibitor 1; TIMP-2—Metalloproteinase inhibitor 2; TNF-α —Tumor necrosis factor alpha; TNF-β —Tumor necrosis factor beta; VEGF—Vascular endothelial growth factor. The explanation of the cytokine abbreviations was obtained from the UniProt Database (http://www.uniprot.org/; accessed 10 October 2021).